This was the stock's second consecutive day of gains.
Walgreens Boots Alliance (NASDAQ:WBA) fell over 7% in extended trading on Thursday after the drugstore chain said it is ...
Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...
We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we ...
Analyst Michael Cherny of Leerink Partners reiterated a Hold rating on Walgreens Boots Alliance (WBA – Research Report), retaining the price ...
Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...
Shares of Walgreens Boots Alliance tumbled after a report that the pharmacy chain’s talks to sell itself to a private-equity firm are unlikely to result in a deal. CNBC’s David Faber said on air his s ...
Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In ...
Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely ...
Shares of Walgreens (NASDAQ: WBA) fell sharply by 9% following reports that a potential acquisition by private equity firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback